BioMed Research International

Sepsis: Pathogenesis, Biomarkers, and Treatment

Publishing date
27 Jun 2014
Submission deadline
07 Feb 2014

1Department of Anesthesiology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Qingchun Road 79, Hangzhou 310003, China

2Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany

3Department of Anesthesiology, Bern University Hospital, 3010 Bern, Switzerland

4Department of Surgery, Children's Hospital, School of Medicine, Zhejiang University, Zhejiang, China

5Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Sepsis: Pathogenesis, Biomarkers, and Treatment


Sepsis is an infection-initiated systemic inflammation syndrome, and it is estimated that ~18 million cases occur annually worldwide. Despite advances in intensive care and supporting technology, the mortality rates of sepsis still range from 15% to 80%, reminding scientists and clinicians that it is still a major challenge. The key to win the “Campaign” to sepsis is the improved understanding of pathogenesis, epidemiological characteristics, novel therapies, and biomarkers for sepsis.

We invite investigators to contribute original research and review articles that seek to investigate the pathogenesis and to introduce novel biomarkers as well as new interventional strategies of sepsis. We are particularly interested in articles describing the host immune response to sepsis, as well as searching the biomarkers and treatment based on immunological findings. And the studies on epidemiology of nosocomial infection initiated sepsis will also be of great interest. Potential topics include, but are not limited to:

  • Advances in pathogenesis of sepsis
  • Resent developments on host immune response in the pathogenesis of sepsis
  • Epidemiology of nosocomial infection initiated sepsis
  • Recent advances in biomarkers to early define sepsis
  • Novel immunological biomarkers of sepsis
  • Advances in novel interventional strategies of sepsis
  • Novel immunological therapies of sepsis

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
Journal Citation Indicator0.610
Impact Factor3.411

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.